Helen Stephens Group’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,000	Closed	-$50.1K	–	87
2024 Q3	$50.1K	Buy	+13,000	New	+$50.1K	0.02%	89